RAPP - CIK 0002012593
Rapport Therapeutics, Inc. has filed 197 documents with the SEC between 2024 and 2026. The most frequent type is insider trade (71 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2026-05-27 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| Insider trade | 4 | 2026-05-13 | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-11 | - |
| Insider trade | 4 | 2026-05-11 | 2026-05-07 |
| Insider sale notice | 144 | 2026-05-08 | - |
| Insider sale notice | 144 | 2026-05-07 | - |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Annual report to shareholders | ARS | 2026-04-23 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-23 | - |
| Proxy statement | DEF 14A | 2026-04-23 | 2026-06-10 |
| Insider trade | 4 | 2026-04-21 | 2026-04-17 |
| Insider trade | 4 | 2026-04-21 | 2026-04-17 |
| Major company event | 8-K | 2026-04-21 | 2026-04-21 |
| Insider sale notice | 144 | 2026-04-17 | - |
| Insider sale notice | 144 | 2026-04-17 | - |
| Insider trade | 4 | 2026-04-14 | 2026-04-10 |
| Insider sale notice | 144 | 2026-04-13 | - |
| Insider sale notice | 144 | 2026-04-10 | - |
| Insider trade | 4 | 2026-04-09 | 2026-04-08 |
| Insider sale notice | 144 | 2026-04-08 | - |
| Insider trade | 4 | 2026-03-31 | 2026-03-30 |
| Insider sale notice | 144 | 2026-03-30 | - |
| Insider trade | 4 | 2026-03-26 | 2026-03-25 |
| Insider sale notice | 144 | 2026-03-25 | - |
| S-3ASR | - | 2026-03-10 | - |
| Employee stock plan | S-8 | 2026-03-10 | - |
| Annual report | 10-K | 2026-03-10 | 2025-12-31 |
| Major company event | 8-K | 2026-03-10 | 2026-03-10 |
| Insider trade | 4 | 2026-03-09 | 2026-03-05 |
| Insider sale notice | 144 | 2026-03-05 | - |
| Insider trade | 4 | 2026-02-19 | 2026-02-18 |
| Insider trade | 4 | 2026-02-19 | 2026-02-17 |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-01-22 | 2026-01-20 |
| SCHEDULE 13G | - | 2026-01-21 | - |
| Insider trade | 4 | 2026-01-16 | 2026-01-15 |
| Insider sale notice | 144 | 2026-01-15 | - |
| Major company event | 8-K | 2026-01-07 | 2026-01-07 |
| Prospectus supplement | 424B5 | 2026-01-07 | - |
| Major company event | 8-K | 2026-01-07 | 2026-01-07 |
| Insider trade | 4 | 2026-01-05 | 2025-12-31 |
| Insider trade | 4 | 2026-01-05 | 2025-12-31 |